Literature DB >> 14493141

An historical account of the study of progressive systemic sclerosis (diffuse scleroderma).

G P RODNAN, T G BENEDEK.   

Abstract

Entities:  

Keywords:  SCLERODERMA/history

Mesh:

Year:  1962        PMID: 14493141     DOI: 10.7326/0003-4819-57-2-305

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.

Authors:  Shiv T Sehra; Andrew Kelly; Joshua F Baker; Chris T Derk
Journal:  Clin Rheumatol       Date:  2016-04-07       Impact factor: 2.980

2.  Systemic sclerosis disease modification clinical trials design: quo vadis?

Authors:  Fabian A Mendoza; Lynette L Keyes-Elstein; Sergio A Jimenez
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-07       Impact factor: 4.794

3.  Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients.

Authors:  A Rajaee; A Ebrahimi; A Fotouhi Ghiam; T Kalantari; A Ghaderi
Journal:  Rheumatol Int       Date:  2005-09-28       Impact factor: 2.631

Review 4.  [Morphology, biochemistry and function of the proteoglycans in dermatology].

Authors:  J Kimmig; H W Kreysel
Journal:  Klin Wochenschr       Date:  1973-03-01

Review 5.  Systemic diseases and the detection of antinuclear and anticytoplasmic antibodies. An historical review.

Authors:  M Walravens
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

6.  Systemic sclerosis mortality in the United States: 1979-1998.

Authors:  Eswar Krishnan; Daniel E Furst
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  Esophageal motor abnormalities in scleroderma and related diseases.

Authors:  T A Saladin; A B French; C J Zarafonetis; H M Pollard
Journal:  Am J Dig Dis       Date:  1966-07

Review 8.  Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.

Authors:  Colin Ligon; Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.592

9.  Turgenev's 'living relic': an early description of scleroderma?

Authors:  Richard M Ellis; Rupak Moitra; Nigel North
Journal:  J R Soc Med       Date:  2005-08       Impact factor: 18.000

10.  Scleroderma-related interstitial lung disease.

Authors:  Sally Suliman; Abdalhamid Al Harash; William Neil Roberts; Rafael L Perez; Jesse Roman
Journal:  Respir Med Case Rep       Date:  2017-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.